Corgenix gains access to Japan diagnostic technology
This article was originally published in Clinica
Executive Summary
Corgenix Medical has entered into an agreement to license a cardiovascular lipid technology that it says could provide better tools for diagnosing atherosclerosis, a cause of heart attacks, strokes and other arterial clotting disorders.